Lyon (France), May 16, 2018 – CALIXAR, the French biotech company specialized in the native isolation of complex therapeutic targets and antigens, is proud to announce its nomination by Patent-Angels.com in Forbes as Best Inventor 2018 of the French Auvergne-Rhône Region among French-Tech start-up companies. At the national level CALIXAR reaches the 38th place out of the Top 100.
This ranking takes into account the total number of different patented inventions hold by each company. With a strong portfolio of 7 patent families, and despite a strong competition, CALIXAR has been able to take the first place of its region.
More information here (article in French).
